Banner Health - Company Profile
Powered by
All the data and insights you need on Banner Health in one report.
- Save hours of research time and resources with
our up-to-date Banner Health Strategy Report
- Understand Banner Health position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Banner Health Catalyst Calendar
Proactively evaluate Banner Health’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Banner Health Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
02 Aug 2022 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
30 Jun 2022 | Phase II Trial Results | AC Immune SA; Banner Alzheimer's Institute; F. Hoffmann-La Roche Ltd; Genentech USA Inc; National Institute on Aging; PRA Health Sciences Inc; U.S. National Institutes of Health; University of Antioquia | ACIU; ROG | crenezumab | Central Nervous System | Alzheimer's Disease | Company SEC Filings |
30 Apr 2022 | Phase II Trial Completion | Banner Alzheimer's Institute; F. Hoffmann-La Roche Ltd; National Institute on Aging | ROG | crenezumab | Central Nervous System | Alzheimer's Disease | Clinical Trial Registry |
22 Mar 2022 | Phase II Trial Completion | AC Immune SA; Banner Alzheimer's Institute; F. Hoffmann-La Roche Ltd; Genentech USA Inc; National Institute on Aging; PRA Health Sciences Inc; U.S. National Institutes of Health; University of Antioquia | ACIU; ROG | crenezumab | Central Nervous System | Alzheimer's Disease | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer